Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignancies
TW201722421A
Use of dianhydrogalactitol or derivatives and analogs thereof for treatment of non-small-cell lung carcinoma, glioblastoma, and ovarian carcinoma by induction of DNA damage and stalling of cell cycle
AU2015240465A1
Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer
CA2931088A1
Hplc analysis of impurities in dianhydrogalactitol
TW201536278A
Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor
US2014315318A1
Analytical methods for analyzing and determining impurities in dianhydrogalactitol
US2014066642A1
Method of synthesis of substituted hexitols such as dianhydrogalactitol
US2014155638A1
Method of synthesis of substituted hexitols such as dianhydrogalactitol
TW201444551A
Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or AHI1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives
US2015182490A1
Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof
BR112014021163A2
improved analytical methods to analyze and determine impurities in dianhydrogalactitol
CN103476250A
Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
CN103270035A
Method of synthesis of substituted hexitols such as dianhydrogalactitol
